Chemotherapy of Breast Cancer: Can We Improve Outcome and Decrease Toxicity by Tailoring Therapy?

By Lidbrink E.   Bergh J.  

American Journal of Cancer, Vol. 1, Iss. 3, 2002-03 ,pp. : 165-171

Adis International

Access to resources Recommend Favorite

Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy

By Vicini F.A.   Remouchamps V.   Wallace M.   Sharpe M.   Fayad J.   Tyburski L.   Letts N.   Kestin L.   Edmundson G.   Pettinga J.   Goldstein N.S.   Wong J.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1247-1253

Elsevier

Access to resources Recommend Favorite

Familial breast cancer in southern Finland - how prevalent are breast cancer families and can we trust the family history reported by patients?

By Eerola H.   Blomqvist C.   Pukkala E.   Pyrhonen S.   Nevanlinna H.  

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1143-1148

Elsevier

Access to resources Recommend Favorite

Can Patients' Likelihood of Benefiting from Primary Chemotherapy for Breast Cancer Be Predicted Before Commencement of Treatment?

By Ogston Keith   Miller Iain   Schofield Andrew   Spyrantis Andreas   Pavlidou Eleni   Sarkar Tarun   Hutcheon Andrew   Payne Simon   Heys Steven  

Breast Cancer Research and Treatment, Vol. 86, Iss. 2, 2004-07 ,pp. : 181-189

Springer Publishing Company

Access to resources Recommend Favorite

How can we improve survival from breast cancer in developing countries?

By Sankaranarayanan Rengaswamy   Alwan Nada   Denny Lynette  

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 179-183

Future Medicine

Access to resources Recommend Favorite